Krystal Biotech Quarterly Balance Sheets Chart
Quarterly
|
Annual
Krystal Biotech Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||
| current assets | |||||||||||||||||||||||||||||||
| cash and cash equivalents | 353,829,000 | 308,770,000 | 344,865,000 | 373,966,000 | 345,786,000 | 359,006,000 | 358,328,000 | 373,241,000 | 275,875,000 | 140,745,000 | 161,900,000 | 186,409,000 | 218,720,000 | 269,303,000 | 341,246,000 | 286,614,000 | 329,527,000 | 402,172,000 | 268,269,000 | 282,369,000 | 291,678,000 | 180,225,000 | 187,514,000 | 194,806,000 | 186,587,000 | 98,013,000 | 103,670,000 | 46,667,000 | 41,813,000 | 47,228,000 | |
| short-term investments | 328,157,000 | 308,076,000 | 252,652,000 | 214,358,000 | 213,826,000 | 179,253,000 | 173,850,000 | 188,828,000 | 201,642,000 | 209,642,000 | 217,271,000 | 208,011,000 | 206,845,000 | 165,329,000 | 96,850,000 | 56,479,000 | 38,203,000 | 1,248,000 | 2,993,000 | 3,996,000 | 5,496,000 | 6,479,000 | 6,171,000 | 8,402,000 | 8,879,000 | 8,617,000 | 8,091,000 | 5,627,000 | 3,637,000 | ||
| accounts receivable | 111,439,000 | 103,260,000 | 104,746,000 | 97,298,000 | 103,236,000 | 46,467,000 | 42,040,000 | 9,316,000 | |||||||||||||||||||||||
| inventory | 31,041,000 | 29,942,000 | 26,508,000 | 18,581,000 | 12,179,000 | 11,037,000 | 6,985,000 | 5,278,000 | |||||||||||||||||||||||
| prepaid expenses and other current assets | 16,881,000 | 16,750,000 | 13,274,000 | 8,961,000 | 7,745,000 | 6,485,000 | 6,706,000 | 5,465,000 | 6,487,000 | 5,042,000 | 4,608,000 | 3,158,000 | 3,205,000 | 3,366,000 | 4,171,000 | 2,719,000 | 2,197,000 | 2,406,000 | 1,287,000 | 1,365,000 | 1,625,000 | ||||||||||
| total current assets | 841,347,000 | 766,798,000 | 742,045,000 | 713,164,000 | 682,772,000 | 602,248,000 | 587,909,000 | 582,128,000 | 484,004,000 | 355,429,000 | 383,779,000 | 397,578,000 | 428,770,000 | 437,998,000 | 442,267,000 | 345,812,000 | 369,927,000 | 405,826,000 | 275,058,000 | 287,652,000 | 298,539,000 | 188,329,000 | 195,880,000 | 204,435,000 | 196,203,000 | 107,894,000 | 112,650,000 | 52,821,000 | 45,710,000 | 47,669,000 | 49,914,000 |
| property and equipment | 150,388,000 | 151,070,000 | 155,168,000 | 156,592,000 | 158,808,000 | 160,011,000 | 161,202,000 | 164,029,000 | 163,737,000 | 163,073,000 | 161,684,000 | 157,786,000 | 151,214,000 | 136,927,000 | 112,355,000 | 78,642,000 | 44,972,000 | 33,883,000 | 30,876,000 | 17,512,000 | 13,215,000 | 10,264,000 | 8,475,000 | 6,863,000 | 5,961,000 | 4,354,000 | 3,014,000 | 1,632,000 | 256,000 | 182,000 | 200,000 |
| long-term investments | 138,807,000 | 148,472,000 | 152,114,000 | 105,888,000 | 69,292,000 | 83,996,000 | 61,954,000 | 36,548,000 | 28,410,000 | 5,129,000 | 4,621,000 | 12,557,000 | 12,902,000 | 33,339,000 | 64,371,000 | 19,237,000 | 21,411,000 | 497,000 | |||||||||||||
| right-of-use assets | 7,655,000 | 7,858,000 | 6,280,000 | 6,471,000 | 6,660,000 | 6,845,000 | 7,027,000 | 7,360,000 | 7,590,000 | 7,814,000 | 8,042,000 | 8,253,000 | 8,279,000 | 8,453,000 | 7,228,000 | 7,342,000 | 7,136,000 | 3,200,000 | 3,298,000 | ||||||||||||
| other non-current assets | 197,000 | 218,000 | 231,000 | 203,000 | 126,000 | 196,000 | 263,000 | 285,000 | 285,000 | 402,000 | 324,000 | 205,000 | 159,000 | 157,000 | 74,000 | 62,000 | 110,000 | 109,000 | 1,612,000 | 1,411,000 | 1,436,000 | 1,505,000 | |||||||||
| total assets | 1,138,394,000 | 1,074,416,000 | 1,055,838,000 | 982,318,000 | 917,658,000 | 853,296,000 | 818,355,000 | 790,350,000 | 684,026,000 | 531,847,000 | 558,450,000 | 576,379,000 | 601,324,000 | 616,874,000 | 626,295,000 | 451,095,000 | 443,556,000 | 443,018,000 | 310,844,000 | 311,451,000 | 318,145,000 | 205,131,000 | 209,023,000 | 214,232,000 | 205,156,000 | 115,704,000 | 116,116,000 | 54,453,000 | 46,030,000 | 47,851,000 | 50,114,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||
| current liabilities | |||||||||||||||||||||||||||||||
| accounts payable | 7,124,000 | 2,672,000 | 4,985,000 | 5,580,000 | 5,425,000 | 5,359,000 | 4,132,000 | 4,340,000 | 4,446,000 | 4,109,000 | 3,981,000 | 5,761,000 | 9,229,000 | 8,209,000 | 8,398,000 | 4,757,000 | 1,265,000 | 1,844,000 | 2,105,000 | 2,591,000 | 1,613,000 | 636,000 | 724,000 | 1,252,000 | 896,000 | 1,126,000 | 888,000 | 378,000 | 214,000 | 89,000 | 193,000 |
| current portion of lease liability | 1,617,000 | 1,362,000 | 1,217,000 | 1,292,000 | 1,361,000 | 1,430,000 | 1,474,000 | 1,501,000 | 1,529,000 | 1,553,000 | 1,561,000 | 1,547,000 | 1,417,000 | 1,411,000 | 1,041,000 | 1,023,000 | 934,000 | 648,000 | 638,000 | 564,000 | 539,000 | 509,000 | 462,000 | 438,000 | 418,000 | ||||||
| accrued rebates | 51,638,000 | 47,405,000 | 36,804,000 | 29,545,000 | 21,733,000 | 11,289,000 | |||||||||||||||||||||||||
| accrued expenses and other current liabilities | 26,517,000 | 28,050,000 | 58,989,000 | 53,110,000 | 43,332,000 | 29,511,000 | 27,488,000 | 21,742,000 | 17,923,000 | 29,414,000 | 23,305,000 | 20,724,000 | 23,781,000 | 50,817,000 | 16,297,000 | 29,999,000 | 15,920,000 | 6,652,000 | 5,109,000 | 4,043,000 | 3,679,000 | 2,916,000 | 2,123,000 | 2,012,000 | 2,606,000 | 1,698,000 | 1,708,000 | 1,538,000 | 545,000 | 363,000 | 447,000 |
| total current liabilities | 86,896,000 | 79,489,000 | 101,995,000 | 89,527,000 | 71,851,000 | 47,589,000 | 33,094,000 | 27,583,000 | 23,898,000 | 35,076,000 | 28,847,000 | 28,032,000 | 34,427,000 | 60,437,000 | 25,736,000 | 35,779,000 | 18,119,000 | 9,144,000 | 15,452,000 | 7,198,000 | 5,831,000 | 4,061,000 | 3,327,000 | 3,726,000 | 3,940,000 | 3,242,000 | 2,596,000 | 1,916,000 | 759,000 | 452,000 | 640,000 |
| lease liability | 8,064,000 | 8,300,000 | 6,044,000 | 6,184,000 | 6,326,000 | 6,465,000 | 6,620,000 | 6,819,000 | 7,014,000 | 7,205,000 | 7,372,000 | 7,575,000 | 7,716,000 | 7,883,000 | 6,983,000 | 7,079,000 | 6,897,000 | 3,222,000 | 3,308,000 | 2,533,000 | 2,618,000 | 2,701,000 | 2,860,000 | 2,926,000 | 2,976,000 | ||||||
| other long-term liabilities | 2,787,000 | 1,953,000 | 1,419,000 | 761,000 | 588,000 | ||||||||||||||||||||||||||
| total liabilities | 97,747,000 | 89,742,000 | 109,458,000 | 96,472,000 | 78,765,000 | 54,054,000 | 39,714,000 | 34,402,000 | 30,912,000 | 42,281,000 | 36,219,000 | 35,607,000 | 42,143,000 | 68,320,000 | 32,719,000 | 42,858,000 | 25,016,000 | 12,366,000 | 18,760,000 | 9,731,000 | 8,449,000 | 6,762,000 | 6,109,000 | 6,586,000 | 6,866,000 | 6,218,000 | 2,890,000 | 2,161,000 | 759,000 | 452,000 | 640,000 |
| commitments and contingencies | |||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000 shares authorized as of june 30, 2025 and december 31, 2024; 28,927 and 28,794 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively. | |||||||||||||||||||||||||||||||
| additional paid-in capital | 1,146,092,000 | 1,129,219,000 | 1,127,238,000 | 1,110,481,000 | 1,092,854,000 | 1,068,436,000 | 1,047,830,000 | 1,034,849,000 | 1,012,616,000 | 815,776,000 | 803,718,000 | 790,954,000 | 779,583,000 | 740,500,000 | 734,523,000 | 527,229,000 | 521,950,000 | 517,675,000 | 363,292,000 | 362,531,000 | 360,877,000 | 242,733,000 | 241,951,000 | 241,325,000 | 227,690,000 | 133,540,000 | 133,183,000 | 68,542,000 | 58,769,000 | 58,619,000 | 58,544,000 |
| accumulated other comprehensive gain | 1,157,000 | 390,000 | -190,000 | 1,512,000 | -634,000 | -299,000 | 638,000 | 2,000 | |||||||||||||||||||||||
| accumulated deficit | -106,602,000 | -144,935,000 | -180,668,000 | -226,147,000 | -253,327,000 | -268,895,000 | -269,827,000 | -278,519,000 | -359,266,000 | -326,056,000 | -280,759,000 | -248,707,000 | -218,857,000 | -190,749,000 | -140,784,000 | -118,978,000 | -103,389,000 | -87,026,000 | -71,214,000 | -60,831,000 | -51,221,000 | -44,388,000 | -39,047,000 | -33,690,000 | -29,418,000 | -24,070,000 | -19,959,000 | -16,251,000 | -13,496,000 | -11,220,000 | -9,070,000 |
| total stockholders’ equity | 1,040,647,000 | 984,674,000 | 946,380,000 | 885,846,000 | 838,893,000 | 799,242,000 | |||||||||||||||||||||||||
| total liabilities and stockholders’ equity | 1,138,394,000 | 1,074,416,000 | 1,055,838,000 | 982,318,000 | 917,658,000 | 853,296,000 | |||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000 shares authorized as of march 31, 2025 and december 31, 2024; 28,899 and 28,794 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively. | |||||||||||||||||||||||||||||||
| stockholders' equity | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000 shares authorized as of december 31, 2024 and 2023; 28,794 and 28,237 shares issued and outstanding as of december 31, 2024 and 2023, respectively. | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000 shares authorized as of september 30, 2024 and december 31, 2023; 28,757 and 28,237 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively. | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000 shares authorized as of june 30, 2024 and december 31, 2023; 28,709 and 28,237 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively. | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000 shares authorized as of march 31, 2024 and december 31, 2023; 28,528 and 28,237 shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively. | |||||||||||||||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at december 31, 2023 and 2022; 28,236,673 and 25,763,743 shares issued and outstanding at december 31, 2023 and 2022, respectively | |||||||||||||||||||||||||||||||
| total stockholders' equity | 778,641,000 | 755,948,000 | 653,114,000 | 489,566,000 | 522,231,000 | 540,772,000 | 559,181,000 | 548,554,000 | 593,576,000 | 408,237,000 | 418,540,000 | 430,652,000 | 292,084,000 | 301,720,000 | 309,696,000 | 198,369,000 | 202,914,000 | 207,646,000 | 198,290,000 | 109,486,000 | 113,226,000 | 52,292,000 | 45,271,000 | 47,399,000 | |||||||
| total liabilities and stockholders' equity | 818,355,000 | 790,350,000 | 684,026,000 | 531,847,000 | 558,450,000 | 576,379,000 | 601,324,000 | 616,874,000 | 626,295,000 | 451,095,000 | 443,556,000 | 443,018,000 | 310,844,000 | 311,451,000 | 318,145,000 | 205,131,000 | 209,023,000 | 214,232,000 | 205,156,000 | 115,704,000 | |||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at september 30, 2023 and december 31, 2022; 28,194,655 shares issued and outstanding at september 30, 2023; and 25,763,743 shares issued and outstanding at december 31, 2022 | |||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -382,000 | -236,000 | -154,000 | -728,000 | -1,475,000 | -1,545,000 | 1,000 | -2,000 | |||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at june 30, 2023 and december 31, 2022; 27,974,916 shares issued and outstanding at june 30, 2023; and 25,763,743 shares issued and outstanding at december 31, 2022 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at march 31, 2023 and december 31, 2022; 25,796,213 shares issued and outstanding at march 31, 2023; and 25,763,743 shares issued and outstanding at december 31, 2022 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at december 31, 2022 and 2021; 25,763,743 and 25,207,985 shares issued and outstanding at december 31, 2022 and 2021, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at september 30, 2022 and december 31, 2021; 2,061,773 shares issued, and no shares outstanding at september 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized a september 30, 2022 and december 31, 2021; 25,709,664 shares issued and outstanding at september 30, 2022; and 25,207,985 shares issued and outstanding at december 31, 2021 | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at june 30, 2022 (unaudited) and december 31, 2021; 2,061,773 shares issued, and no shares outstanding at june 30, 2022 (unaudited) and december 31, 2021 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at june 30, 2022 (unaudited) and december 31, 2021; 25,664,287 shares issued and outstanding at june 30, 2022 (unaudited); and 25,207,985 shares issued and outstanding at december 31, 2021 | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at march 31, 2022 (unaudited) and december 31, 2021; 2,061,773 shares issued, and no shares outstanding at march 31, 2022 (unaudited) and december 31, 2021 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at march 31, 2022 (unaudited) and december 31, 2021; 25,199,081 shares issued and outstanding at march 31, 2022 (unaudited); and 25,207,985 shares issued and outstanding at december 31, 2021 | |||||||||||||||||||||||||||||||
| accumulated other comprehensive expense | -1,197,000 | ||||||||||||||||||||||||||||||
| build-to-suit lease liability | 7,600,000 | ||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at december 31, 2021 and 2020; 2,061,773 shares issued, and no shares outstanding at december 31, 2021 and 2020 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at december 31, 2021 and 2020; 25,207,985 and 19,714,220 shares issued and outstanding at december 31, 2021 and 2020, respectively | |||||||||||||||||||||||||||||||
| accumulated other comprehensive income | -163,000 | -14,000 | -21,000 | 3,000 | 6,000 | 20,000 | 40,000 | 24,000 | 10,000 | 11,000 | 18,000 | 16,000 | |||||||||||||||||||
| build to suit lease liability | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at september 30, 2021 (unaudited) and december 31, 2020; 2,061,773 shares issued, and no shares outstanding at september 30, 2021 (unaudited) and december 31, 2020 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at september 30, 2021 (unaudited) and december 31, 2020; 22,237,984 and 19,714,220 shares issued and outstanding at september 30, 2021 (unaudited) and december 31, 2020, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at june 30, 2021 (unaudited) and december 31, 2020; 2,061,773 shares issued, and no shares outstanding at june 30, 2021 (unaudited) and december 31, 2020 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at june 30, 2021 (unaudited) and december 31, 2020; 22,205,032 and 19,714,220 shares issued and outstanding at june 30, 2021 (unaudited) and december 31, 2020, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at march 31, 2021 (unaudited) and december 31, 2020; 2,061,773 shares issued, and no shares outstanding at march 31, 2021 (unaudited) and december 31, 2020 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at march 31, 2021 (unaudited) and december 31, 2020; 22,204,057 and 19,714,220 shares issued and outstanding at march 31, 2021 (unaudited) and december 31, 2020, respectively | |||||||||||||||||||||||||||||||
| prepaid and other current assets | 3,796,000 | 2,195,000 | 1,227,000 | 737,000 | 1,264,000 | 889,000 | 527,000 | 260,000 | 441,000 | ||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at december 31, 2020 and 2019; 2,061,773 shares issued, and no shares outstanding at december 31, 2020 and 2019 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at december 31, 2020 and 2019; 19,714,220 and 17,354,310 shares issued and outstanding at december 31, 2020 and 2019, respectively | |||||||||||||||||||||||||||||||
| prepaid rent | 2,400,000 | 2,400,000 | 2,400,000 | ||||||||||||||||||||||||||||
| right-of-use asset | 2,476,000 | 2,555,000 | 2,633,000 | 2,709,000 | 2,796,000 | 2,906,000 | 3,001,000 | ||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at september 30, 2020 (unaudited) and december 31, 2019; 2,061,773 shares issued, and no shares outstanding at september 30, 2020 (unaudited) and december 31, 2019 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at september 30, 2020 (unaudited) and december 31, 2019; 19,706,870 and 17,354,310 shares issued and outstanding at september 30, 2020 (unaudited) and december 31, 2019, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at june 30, 2020 (unaudited) and december 31, 2019; 2,061,773 shares issued, and no shares outstanding at june 30, 2020 (unaudited) and december 31, 2019 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at june 30, 2020 (unaudited) and december 31, 2019; 19,664,059 and 17,354,310 shares issued and outstanding at june 30, 2020 (unaudited) and december 31, 2019, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at march 31, 2020 (unaudited) and december 31, 2019; 2,061,773 shares issued, and no shares outstanding at march 31, 2020 (unaudited) and december 31, 2019 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at march 31, 2020 (unaudited) and december 31, 2019; 17,370,564 and 17,354,310 shares issued and outstanding at march 31, 2020 (unaudited) and december 31, 2019, respectively | |||||||||||||||||||||||||||||||
| other noncurrent assets | 1,462,000 | 138,000 | 86,000 | 455,000 | 452,000 | 64,000 | |||||||||||||||||||||||||
| current portion of lease liabilities | 480,000 | ||||||||||||||||||||||||||||||
| lease liabilities | 2,782,000 | ||||||||||||||||||||||||||||||
| other noncurrent liabilities | 294,000 | 245,000 | |||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at december 31, 2019 and 2018; 2,061,773 shares issued, and no shares outstanding at december 31, 2019 and 2018 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at december 31, 2019 and 2018; 17,354,310 and 14,428,916 shares issued and outstanding at december 31, 2019 and 2018, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at september 30, 2019 (unaudited) and december 31, 2018; 2,061,773 shares issued, and no shares outstanding at september 30, 2019 (unaudited) and december 31, 2018 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at september 30, 2019 (unaudited) and december 31, 2018; 17,307,640 and 14,428,916 shares issued and outstanding at september 30, 2019 (unaudited) and december 31, 2018, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at june 30, 2019 (unaudited) and december 31, 2018; 2,061,773 shares issued, and no shares outstanding at june 30, 2019 (unaudited) and december 31, 2018 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at june 30, 2019 (unaudited) and december 31, 2018; 16,945,069 and 14,428,916 shares issued and outstanding at june 30, 2019 (unaudited) and december 31, 2018, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at march 31, 2019 (unaudited) and december 31, 2018; 2,061,773 shares issued, and no shares outstanding at march 31, 2019 (unaudited) and december 31, 2018 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at march 31, 2019 (unaudited) and december 31, 2018; 14,443,569 and 14,428,916 shares issued and outstanding at march 31, 2019 (unaudited) and december 31, 2018, respectively | |||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock, stockholders' and members’ equity | |||||||||||||||||||||||||||||||
| preferred stock | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at december 31, 2018 and 2017; 2,061,773 shares issued, and no shares outstanding at december 31, 2018 and 2017 | |||||||||||||||||||||||||||||||
| total preferred stock | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at december 31, 2018 and 2017; 14,428,916 and 10,307,247 shares issued and outstanding at december 31, 2018 and 2017, respectively | |||||||||||||||||||||||||||||||
| total liabilities, preferred stock and stockholders' equity | 116,116,000 | 54,453,000 | 46,030,000 | 47,851,000 | |||||||||||||||||||||||||||
| liabilities, preferred stock and stockholders' equity | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at september 30, 2018 (unaudited) and december 31, 2017; 2,061,773 shares issued, and no shares outstanding at september 30, 2018 (unaudited) and december 31, 2017 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at september 30, 2018 (unaudited) and december 31, 2017; 10,978,916 and 10,307,247 shares issued and outstanding at september 30, 2018 (unaudited) and december 31, 2017, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at june 30, 2018 (unaudited) and december 31, 2017; 2,061,773 shares issued, and no shares outstanding at june 30, 2018 (unaudited) and december 31, 2017 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at june 30, 2018 (unaudited) and december 31, 2017; 10,353,916 and 10,307,247 shares issued and outstanding at june 30, 2018 (unaudited) and december 31, 2017, respectively | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized at march 31, 2018 (unaudited) and december 31, 2017; 2,061,773 shares issued, and no shares outstanding at march 31, 2018 (unaudited) and december 31, 2017 | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized at march 31, 2018 (unaudited) and december 31, 2017; 10,309,615 and 10,307,247 shares issued and outstanding at march 31, 2018 (unaudited) and december 31, 2017, respectively | |||||||||||||||||||||||||||||||
| cash | 49,591,000 | ||||||||||||||||||||||||||||||
| prepaid assets | 304,000 | ||||||||||||||||||||||||||||||
| other current assets | 19,000 | ||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders' and members’ equity | |||||||||||||||||||||||||||||||
| accrued interest | |||||||||||||||||||||||||||||||
| related party convertible promissory notes | |||||||||||||||||||||||||||||||
| convertible promissory notes | |||||||||||||||||||||||||||||||
| preferred stock; 0.00001 par value; 20,000,000 shares authorized, 2,061,773 shares issued, and no shares outstanding at december 31, 2017; no shares authorized, issued, or outstanding at december 31, 2016 | |||||||||||||||||||||||||||||||
| stockholders' and members’ equity | |||||||||||||||||||||||||||||||
| common stock; 0.00001 par value; 80,000,000 shares authorized, 10,307,247 shares issued and outstanding at december 31, 2017; no shares authorized, issued, or outstanding at december 31, 2016 | |||||||||||||||||||||||||||||||
| common units; no par value; no common units authorized, issued, or outstanding at december 31, 2017; 3,490,884 units authorized, issued, and outstanding at december 31, 2016 | |||||||||||||||||||||||||||||||
| preferred units; no par value; no preferred units authorized, issued, or outstanding at december 31, 2017; 179,613 units authorized, issued, and outstanding at december 31, 2016 | |||||||||||||||||||||||||||||||
| total stockholders' and members’ equity | 49,474,000 | ||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock and stockholders' and members’ equity | 50,114,000 |
We provide you with 20 years of balance sheets for Krystal Biotech stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Krystal Biotech. Explore the full financial landscape of Krystal Biotech stock with our expertly curated balance sheets.
The information provided in this report about Krystal Biotech stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.